AAIC26: Cognito sheds light on biological underpinnings of Alzheimer’s headset

Spectris increased CSF levels of multiple HDL-like lipid transport proteins, suggesting a “coordinated biological response” to the neuromodulation therapy. Spectris increased CSF levels of multiple HDL-like lipid transport proteins, suggesting a “coordinated biological response” to the neuromodulation therapy. Cognito said the latest findings add to its understanding about its Spectris neuromodulation system’s mechanism of action in Alzheimer’s disease. Credit: Marko Aliaksandr/Shutterstock.com New data from Cognito Therapeutics has indicated that its Spectris device increases cerebrospinal fluid (CSF) HDL-like lipid transport particles, suggesting the neuromodulation therapy prompts a “coordinated biological response” in patients with mild cognitive impairment (MCI). Spectris is an investigational…

Source: Medical Device Network